Meeting of the COVID-19 Health Equity Task Force, 20374-20375 [2021-08002]

Download as PDF 20374 Federal Register / Vol. 86, No. 73 / Monday, April 19, 2021 / Notices HRSA specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, (2) the accuracy of the estimated burden, (3) ways to enhance the quality, utility, and clarity of the information to be collected, and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2021–07971 Filed 4–16–21; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: National Survey of Organ Donation Attitudes and Practices, OMB No. 0915–0290— Extension Health Resources and Services Administration (HRSA), Department of Health and Human Services. AGENCY: ACTION: Notice. In compliance with the Paperwork Reduction Act of 1995, HRSA announces plans to submit an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the public SUMMARY: regarding the burden estimate below or any other aspect of the ICR. DATES: Comments on this ICR should be received no later than June 18, 2021. ADDRESSES: Submit your comments to paperwork@hrsa.gov or mail the HRSA Information Collection Clearance Officer, 14N136B, 5600 Fishers Lane, Rockville, MD 20857. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the data collection plans and draft instruments, email paperwork@hrsa.gov or call Lisa Wright-Solomon, the HRSA Information Collection Clearance Officer at (301) 443–1984. SUPPLEMENTARY INFORMATION: When submitting comments or requesting information, please include the information request collection title for reference. Information Collection Request Title: National Survey of Organ Donation Attitudes and Practices, OMB No. 0915– 0290—Extension. Abstract: HRSA is requesting approval by OMB for a revision of a previously approved collection of information (OMB control number 0915–0290). The National Survey of Organ Donation Attitudes and Practices (NSODAP) is conducted approximately every 6–7 years and serves a critical role in providing HRSA and the donation community with data regarding why Americans choose to donate organs, current barriers to donation, and possible paths to increasing donations. Survey data and derived analytic insights help HRSA develop and target appropriate messages for public outreach and educational initiatives. Need and Proposed Use of the Information: HRSA is the primary federal entity responsible for oversight of the solid organ and blood stem cell transplant systems and initiatives to increase organ donor registration and donation in the United States. This survey is the primary method by which HRSA can obtain information from Americans about organ donation attitudes and beliefs. OMB previously approved this survey and HRSA fielded it during 2005, 2012, and 2019. Results of the data collected from this survey will help develop appropriate messages for future public outreach and educational initiatives to increase awareness about organ donation and ultimately the number of registered donors. Likely Respondents: A nationally representative sample of adults over the age of 18 with a higher number of responses from populations of interest such as racial-ethnic minorities, including African American, Asian, Native American, and Hispanic respondents, as well as respondents of all age groups and education levels. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose, or provide the information requested. This includes the time needed to review instructions; to develop, acquire, install, and utilize technology and systems for collecting, validating, verifying, processing and maintaining information, and disclosing and providing information; to train personnel and be able to respond to a collection of information; to search data sources; to complete and review the collection of information, and to transmit or otherwise disclose the information. A summary of the total annual burden hours estimated for this ICR is in the table below. TOTAL ESTIMATED ANNUALIZED BURDEN HOURS jbell on DSKJLSW7X2PROD with NOTICES Number of responses per respondent Number of respondents Form name Total responses Average burden per response (in hours) Total burden hours NSODAP Revised Survey—Telephone ............................. NSODAP Revised Survey—Online Panel ......................... 2,000 8,000 1 1 2,000 8,000 0.37 0.27 740 2,160 Total ............................................................................ 10,000 .......................... 10,000 ........................ 2,900 HRSA specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques VerDate Sep<11>2014 17:11 Apr 16, 2021 Jkt 253001 or other forms of information technology to minimize the information collection burden. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2021–07996 Filed 4–16–21; 8:45 am] BILLING CODE 4165–15–P PO 00000 Frm 00014 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the COVID–19 Health Equity Task Force Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. AGENCY: E:\FR\FM\19APN1.SGM 19APN1 Federal Register / Vol. 86, No. 73 / Monday, April 19, 2021 / Notices ACTION: Notice of meeting. As required by the Federal Advisory Committee Act, the U.S. Department of Health and Human Services (HHS) is hereby giving notice that the COVID–19 Health Equity Task Force (Task Force) will hold a virtual meeting on April 30, 2021. The purpose of this meeting is to consider interim recommendations specific to mental and behavioral health across the life course. This meeting is open to the public and will be live-streamed at www.hhs.gov/ live. Information about the meeting will be posted on the HHS Office of Minority Health website: www.minorityhealth.hhs.gov/ healthequitytaskforce/ prior to the meeting. DATES: The Task Force meeting will be held on Friday, April 30, 2021, from 2 p.m. to approximately 6 p.m. ET (date and time are tentative and subject to change). The confirmed time and agenda will be posted on the COVID–19 Health Equity Task Force web page: www.minorityhealth.hhs.gov/ healthequitytaskforce/ when this information becomes available. FOR FURTHER INFORMATION CONTACT: Minh Wendt, Designated Federal Officer for the Task Force; Office of Minority Health, Department of Health and Human Services, Tower Building, 1101 Wootton Parkway, Suite 100, Rockville, Maryland 20852. Phone: 240–453–6160; email: COVID19HETF@hhs.gov. SUPPLEMENTARY INFORMATION: Background: The COVID–19 Health Equity Task Force (Task Force) was established by Executive Order 13995, dated January 21, 2021. The Task Force is tasked with providing specific recommendations to the President, through the Coordinator of the COVID– 19 Response and Counselor to the President (COVID–19 Response Coordinator), for mitigating the health inequities caused or exacerbated by the COVID–19 pandemic and for preventing such inequities in the future. The Task Force shall submit a final report to the COVID–19 Response Coordinator addressing any ongoing health inequities faced by COVID–19 survivors that may merit a public health response, describing the factors that contributed to disparities in COVID–19 outcomes, and recommending actions to combat such disparities in future pandemic responses. The meeting is open to the public and will be live-streamed at www.hhs.gov/ live. No registration is required. A public comment session will be held during the meeting. Pre-registration is required to provide public comment jbell on DSKJLSW7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:11 Apr 16, 2021 Jkt 253001 20375 during the meeting. To pre-register, please send an email to COVID19HETF@hhs.gov and include your name, title, and organization by close of business on Friday, April 23, 2021. Comments will be limited to no more than three minutes per speaker and should be pertinent to the meeting discussion. Individuals are encouraged to provide a written statement of any public comment(s) for accurate minutetaking purposes. If you decide you would like to provide public comment but do not pre-register, you may submit your written statement by emailing COVID19HETF@hhs.gov no later than close of business on Thursday, May 6, 2021. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should contact: COVID19HETF@hhs.gov and reference this meeting. Requests for special accommodations should be made at least 10 business days prior to the meeting. Contact Person: Svetlana Kotliarova, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6214, Bethesda, MD 20892, 301–594–7945, kotliars@mail.nih.gov. Name of Committee: Oncology 2— Translational Clinical Integrated Review Group; Cancer Prevention Study Section. Date: June 17–18, 2021. Time: 9:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Svetlana Kotliarova, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6214, Bethesda, MD 20892, 301–594–7945, kotliars@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: April 5, 2021. Minh Wendt, Designated Federal Officer, COVID–19 Health Equity Task Force. Dated: April 14, 2021. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–08002 Filed 4–16–21; 8:45 am] [FR Doc. 2021–07981 Filed 4–16–21; 8:45 am] BILLING CODE 4150–29–P BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Substance Abuse and Mental Health Services Administration Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; NIH Research Enhancement Award (R15) in Oncological Sciences. Date: May 26, 2021. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). PO 00000 Frm 00015 Fmt 4703 Sfmt 4703 Advisory Committee for Women’s Services (ACWS); Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given of a meeting of the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Advisory Committee for Women’s Services (ACWS) on May 5, 2021. The meeting will include discussions on assessing SAMHSA’s current strategies, including the mental health and substance use needs of the women and girls population. Additionally, the ACWS will be addressing priorities regarding the impact of COVID–19 on the behavioral health needs of women and children and directions around behavioral health services and access for women and children. The meeting is open to the public and will be held virtually. Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions should be forwarded to the contact person by April 30, 2021. Oral presentations from the public will be scheduled at the conclusion of the E:\FR\FM\19APN1.SGM 19APN1

Agencies

[Federal Register Volume 86, Number 73 (Monday, April 19, 2021)]
[Notices]
[Pages 20374-20375]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-08002]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the COVID-19 Health Equity Task Force

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

[[Page 20375]]


ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: As required by the Federal Advisory Committee Act, the U.S. 
Department of Health and Human Services (HHS) is hereby giving notice 
that the COVID-19 Health Equity Task Force (Task Force) will hold a 
virtual meeting on April 30, 2021. The purpose of this meeting is to 
consider interim recommendations specific to mental and behavioral 
health across the life course. This meeting is open to the public and 
will be live-streamed at www.hhs.gov/live. Information about the 
meeting will be posted on the HHS Office of Minority Health website: 
www.minorityhealth.hhs.gov/healthequitytaskforce/ prior to the meeting.

DATES: The Task Force meeting will be held on Friday, April 30, 2021, 
from 2 p.m. to approximately 6 p.m. ET (date and time are tentative and 
subject to change). The confirmed time and agenda will be posted on the 
COVID-19 Health Equity Task Force web page: www.minorityhealth.hhs.gov/healthequitytaskforce/ when this information becomes available.

FOR FURTHER INFORMATION CONTACT: Minh Wendt, Designated Federal Officer 
for the Task Force; Office of Minority Health, Department of Health and 
Human Services, Tower Building, 1101 Wootton Parkway, Suite 100, 
Rockville, Maryland 20852. Phone: 240-453-6160; email: 
[email protected].

SUPPLEMENTARY INFORMATION:
    Background: The COVID-19 Health Equity Task Force (Task Force) was 
established by Executive Order 13995, dated January 21, 2021. The Task 
Force is tasked with providing specific recommendations to the 
President, through the Coordinator of the COVID-19 Response and 
Counselor to the President (COVID-19 Response Coordinator), for 
mitigating the health inequities caused or exacerbated by the COVID-19 
pandemic and for preventing such inequities in the future. The Task 
Force shall submit a final report to the COVID-19 Response Coordinator 
addressing any ongoing health inequities faced by COVID-19 survivors 
that may merit a public health response, describing the factors that 
contributed to disparities in COVID-19 outcomes, and recommending 
actions to combat such disparities in future pandemic responses.
    The meeting is open to the public and will be live-streamed at 
www.hhs.gov/live. No registration is required. A public comment session 
will be held during the meeting. Pre-registration is required to 
provide public comment during the meeting. To pre-register, please send 
an email to [email protected] and include your name, title, and 
organization by close of business on Friday, April 23, 2021. Comments 
will be limited to no more than three minutes per speaker and should be 
pertinent to the meeting discussion. Individuals are encouraged to 
provide a written statement of any public comment(s) for accurate 
minute-taking purposes. If you decide you would like to provide public 
comment but do not pre-register, you may submit your written statement 
by emailing [email protected] no later than close of business on 
Thursday, May 6, 2021. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should contact: [email protected] and reference this 
meeting. Requests for special accommodations should be made at least 10 
business days prior to the meeting.

    Dated: April 5, 2021.
Minh Wendt,
Designated Federal Officer, COVID-19 Health Equity Task Force.
[FR Doc. 2021-08002 Filed 4-16-21; 8:45 am]
BILLING CODE 4150-29-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.